SCHEMBL10185835

SCHEMBL10185835

Cn1ccc(N(C(O)Cn2cnc3ccccc32)C2C(=O)N(C3CCCCC3)c3ccccc32)n1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 4/20 0.38
▸ LMNA P02545 3/20 0.38
▸ HTT P42858 3/20 0.38
▸ NPSR1 Q6W5P4 2/20 0.38
▸ OPRM1 P35372 4/20 0.37
▸ OPRK1 P41145 4/20 0.37
▸ OPRL1 P41146 3/20 0.37
▸ HRH3 Q9Y5N1 2/20 0.36
▸ AGER Q15109 4/20 0.35
▸ APAF1 O14727 1/20 0.35
▸ ADRA2A P08913 1/20 0.35
▸ GGPS1 O95749 1/20 0.34
▸ FDPS P14324 1/20 0.34
▸ POLB P06746 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ HSD17B10 Q99714 1/20 0.34
▸ OPRD1 P41143 1/20 0.33
▸ OGFRL1 Q5TC84 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10183302 0.73 PTAFR (0.41) LMNAHTTOPRM1OPRK1OPRL1
SCHEMBL10185523 0.73 IDH1 (0.36) OPRM1OPRK1OPRL1ALDH1A1
SCHEMBL10184173 0.72 OPRM1 (0.37) OPRM1OPRK1OPRL1
SCHEMBL10183722 0.70 TP53 (0.41) TSHRLMNAHTTNPSR1OPRM1
SCHEMBL10183670 0.68 TRPM8 (0.41) NPSR1OPRM1OPRK1OPRL1POLB
SCHEMBL10183290 0.68 IDH1 (0.50) TSHRLMNAHTTNPSR1HRH3
SCHEMBL10183929 0.67 CHRM2 (0.43) TSHROPRM1OPRK1OPRL1MAPT
SCHEMBL10183271 0.66 MAPT (0.42) LMNANPSR1OPRM1OPRK1OPRL1
SCHEMBL10185869 0.63 OPRM1 (0.40) LMNAOPRM1OPRK1OPRL1MAPT
SCHEMBL10185837 0.62 OPRM1 (0.34) OPRM1OPRK1OPRL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012009678-A1 THERAPEUTICALLY ACTIVE COMPOSITIONS AND THEIR METHOD OF USE AGIOS PHARMACEUTICALS, INC. (US) 2012-01-19 — — WO disclosed
Send feedback